Payfare generated unaudited net income of $4.9 million, and Adjusted net income per share1 of $0.15 in Q4 2023. The Company has also provided an update on its Annual Filings.

VANCOUVER, BC and TORONTO, April 26, 2024 /CNW/ - Silvercorp Metals Inc. ("Silvercorp") (TSX: SVM) (NYSE American: SVM) and Adventus Mining Corporation ("Adventus") (TSXV: ADZN) (OTCQX: ADVZF) are pleased to announce that the parties have entered into a definitive arrangement agreement (the "Arrangement Agreement") pursuant to which Silvercorp has agreed to acquire all of the issued and outstanding common shares of Adventus (the "Transaction") by way of a plan of arrangement (the "Arrangement").

MONTREAL, April 25, 2024 /CNW/ - Velan Inc. ("Velan") (TSX: VLN) today announces that its Board of Directors has appointed Mr. Daniel Desjardins as an independent director of Velan.

TORONTO, April 25, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 fiscal 2024 financial results on Thursday, May 9, 2024. The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. The call will be hosted by Mr. Craig Millian, Chief Executive Officer and Mr. John Hanna, Interim Chief Financial Officer. Slides to accompany management's prepared remarks will be available to view via the webcast.